GW & Wade’s Teladoc Health TDOC Stock Holding History

GW & Wade’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,101	Closed	-$224K	–	402
2022 Q1	$224K	Buy	+3,101	New	+$223K	0.01%	365

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

GW & Wade's TDOC Position: Q2 2022 in Review

GW & Wade sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 3,101 shares — an estimated $224K sold.

GW & Wade first reported a position in TDOC in Q1 2022 and held it in 1 quarter. The position peaked at $224K in Q1 2022. 550 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

GW & Wade reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
GW & Wade sold 3,101 Teladoc Health shares in Q2 2022, an estimated $224K.
GW & Wade first reported a position in Teladoc Health in Q1 2022 and held it in 1 quarter.
GW & Wade's Teladoc Health position peaked at $224K in Q1 2022.
550 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on GW & Wade's 13F filing for Q2 2022, filed 9 Aug 2022.